Correlation Between Oramed Pharmaceuticals and Enanta Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Oramed Pharmaceuticals and Enanta Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oramed Pharmaceuticals and Enanta Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oramed Pharmaceuticals and Enanta Pharmaceuticals, you can compare the effects of market volatilities on Oramed Pharmaceuticals and Enanta Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oramed Pharmaceuticals with a short position of Enanta Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oramed Pharmaceuticals and Enanta Pharmaceuticals.
Diversification Opportunities for Oramed Pharmaceuticals and Enanta Pharmaceuticals
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Oramed and Enanta is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Oramed Pharmaceuticals and Enanta Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enanta Pharmaceuticals and Oramed Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oramed Pharmaceuticals are associated (or correlated) with Enanta Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enanta Pharmaceuticals has no effect on the direction of Oramed Pharmaceuticals i.e., Oramed Pharmaceuticals and Enanta Pharmaceuticals go up and down completely randomly.
Pair Corralation between Oramed Pharmaceuticals and Enanta Pharmaceuticals
Given the investment horizon of 90 days Oramed Pharmaceuticals is expected to generate 0.94 times more return on investment than Enanta Pharmaceuticals. However, Oramed Pharmaceuticals is 1.07 times less risky than Enanta Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Enanta Pharmaceuticals is currently generating about -0.5 per unit of risk. If you would invest 238.00 in Oramed Pharmaceuticals on September 1, 2024 and sell it today you would lose (1.00) from holding Oramed Pharmaceuticals or give up 0.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oramed Pharmaceuticals vs. Enanta Pharmaceuticals
Performance |
| Timeline |
| Oramed Pharmaceuticals |
| Enanta Pharmaceuticals |
Oramed Pharmaceuticals and Enanta Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oramed Pharmaceuticals and Enanta Pharmaceuticals
The main advantage of trading using opposite Oramed Pharmaceuticals and Enanta Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oramed Pharmaceuticals position performs unexpectedly, Enanta Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enanta Pharmaceuticals will offset losses from the drop in Enanta Pharmaceuticals' long position.The idea behind Oramed Pharmaceuticals and Enanta Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |